Accredited clinical laboratory and life sciences company

2009

Curila K, Benesova L, Penicka M, Minarik M, Zemanek D, Veselka J, Widimsky P, Gregor P. Low Prevalence and Variable Clinical Presentation of Troponin I and Troponin T Gene Mutations in Hypertrophic Cardiomyopathy. Genet Test Mol Biomarkers. 2009 13, 647-650. IF 1,170


Pesek M, Benesova L, Belsanova B, Mukensnabl P, Bruha F, Minarik M. Dominance of EGFR and insignificant KRAS mutations in prediction of tyrosine-kinase therapy for NSCLC patients stratified by tumor subtype and smoking status. Anticancer Res. 2009, 29, 2767-2773. IF 1,428


Salek, C., Minarikova, P., Benesova, L., Nosek, V., Strnad, R., Zavoral, M., Minarik M. Mutation Status of K-Ras, P53 and Allelic Losses at 9p and 18q Are Not Prognostic Markers in Patients with Pancreatic Cancer, Anticancer Res. 2009 May;29(5):1803-10.


Prochazkova K, Pavlikova K, Minarik M, Sumerauer D, Kodet R, Sedlacek Z. Somatic TP53 mutation mosaicism in a patient with Li-Fraumeni syndrome. Am J Med Genet A. 2009, 149A, 206-211.